Search database
LIST OPTIONS
Filter
87
Filtered Results: 87
Text search: DNDi 
Featured
Language
Document type
Studies & Reports
27
No document type
20
Guidelines
8
Videos
7
Strategic & Response Plan
7
Resource Platforms
5
Manuals
4
Fact sheets
4
Situation Updates
3
Infographics
2
Countries / Regions
Global
12
Latin America and the Carribbean
6
Africa
5
Colombia
3
Ethiopia
3
Kenya
2
West and Central Africa
2
East and Southern Africa
2
Southern Africa
2
Brazil
2
Asia
1
Congo, Democratic Republic of
1
South–East Asia Region
1
North America
1
Uruguay
1
Argentina
1
Bangladesh
1
Uganda
1
Zambia
1
India
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
15
World Health Organization WHO
12
et al.
6
World Health Organization (WHO)
6
DNDi - Drugs for neglected diseases initiative
5
Forsyth, C.
4
Kita, K.
4
Nagasaki University School of Tropical Medicine and Global Health
4
Unitaid
4
Yamada, H.
4
PLOS Neglected Tropical Diseases
3
World Health Organisation (WHO)
3
Dahal, P.
2
Drugs for Neglected Diseases initiative DNDi - Latin America
2
A.Hill, T. Swan and K.Timmermans
1
Aksoy, S.
1
Avaria, A. et al.
1
Batista, C.
1
Bayão T.S., Cupertino M.C., Gomes A.P. et al
1
Bernal, O.
1
Bernal, OA
1
Bernhard, S.
1
Brindley, P. et al.
1
Brot für die Welt
1
BUKO Pharma-Kampagne
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
Burri, C.
1
Caicedo Díaz, RA,
1
Chagas Coalition
1
Diseases
1
DNDi 
1
DNDi Latin America
1
Drugs for Neglected Diseases Initiative DNDi Latin America
1
E. André
1
Ethiopia, Ministry of Health
1
Fanjul, G.
1
Federal Ministry of Health, Ethiopia
1
Foundation for innovative new diagnostics FIND
1
Frontiers in Pediatrics
1
GARDP Global Acntibiotic Research & Dedvelopment Partnership
1
Ghanei, M.
1
Global Health Alliance-Deutschland (GHA-D)
1
HAT & OND Team
1
HELP - Helminth Elimination Platform
1
Herazo, F.
1
Hommes F, Stratil J, Ströbele L, Bruchhausen W
1
Hotez, P.
1
Jornal of Global Health Science
1
Journal of the Brazilian Society of Tropical Medicine
1
Kaiser, M.
1
Kamhawi, S.
1
Khan, J.
1
LEAP
1
Luquetti, A.
1
Maguire, B.
1
Maguire, B.J.
1
Marchiol, A
1
Mark F. Cotton
1
Mäser, P.
1
McGloin, J.
1
Medécins sans Frontières MSF
1
Médecins Sans Frontières
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health Ethiopia
1
Moriana, S.
1
MSF Access Campaign
1
National HIV
1
Organización Panamericana de la Salud
1
Oritz, G.
1
PAHO, WHO
1
Pan American Health Organisation PAHO
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO
1
Pan American Health Organization PAHO - World Health Organization WHO
1
Pan American Journal of Public Health
1
Rafati, S.
1
Rashan, S.
1
Rashan, S. et al.
1
S. H.-L. Fry
1
S. L. Barnabas
1
Sanmatino, M.
1
Tavares, S.
1
TB Alliance
1
Unicef
1
UNICEF, UNESCO, Asia Pacific Network of People living with HIV
1
Valentuela, J.
1
Wamai, R.
1
World Health Organization (Western Pacific Region)
1
World Metrological Organisation - WMO
1
Zaidel, E.J.
1
Ziaggi, G.
1
Publication Years
Category
Studies & Reports
5
Chagas
4
Guidelines
4
Leishmaniasis
4
Statistics
3
Disease Prevention & Control
3
Hepatitis
2
Pediatrics
2
Policies & Guidelines HIV & TB
2
Policies
2
NTDs & Others
2
HIV & STI
2
Pharmacy & Technologies
2
COVID-19
1
Virology
1
Medical Devices & Equipment
1
Drugs & Medical Equipment
1
Parasitology
1
Human African Trypanosomiasis
1
Non-communicable Diseases
1
Toolboxes
Capacity Building & Resources
7
Studies & Reports
6
Strategies & Roadmaps
5
Clinical Aspects & Diagnostics
5
Studies & Reports
5
Studies & Reports
4
Clinical Aspects & Diagnostics
3
Local Action
2
Essential Medicines
2
Capacity Building & Resources
2
Information & Education Material (IEC)
2
Statistics & Facts
2
Overview, Studies & Reports
2
Antiretroviral Treatment ART
2
ART Drug Resistance
1
Agriculture & Veterinary
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
Opportunistic Infections
1
Introduction to Global Health
1
Prevention Guidelines
1
Treatment Guidelines HIV
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Children
1
Health Equity & Equality
1
Health Personnel
1
Country specific documents
1
Long COVID/ Post-COVID Syndrome
1
Advocacy & Communication
1
Climate Change General
1
Prices and Patents
1
Chagas
1
Leishmaniasis
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
NTDs General
1
Vector control
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Information & Education Material (IEC)
1
Access to treatment and laboratory
1
Health Financing Toolbox
1
Information & Education Material (IEC)
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Human Rights & the Right to Health
1
HIV service delivery
1
AMR
1
Reports & Studies
1
Accessed on 04.04.2023 Die Initiative Medikamente gegen vernachlässigte Krankheiten (Drugs for Neglected Diseases initiative, DNDi) ist eine internationale gemeinnützige Organisation, die sichere, wirksame und bezahlbare Behandlungen für die am meisten vernachlässigten Patient:innen erforsch... more
Accessed on 04.04.2023 A Iniciativa Medicamentos para Doenças Negligenciadas (DNDi) é uma organização internacional sem fins lucrativos que disponibiliza medicamentos seguros, eficazes e acessíveis para doenças negligenciadas, desde o laboratório até sua chegada às mãos das popula... more
Accessed on 04.04.2023 L’initiative Médicaments contre les Maladies Négligées (DNDi) est une organisation internationale à but non lucratif spécialisée dans la recherche, le développement et la mise à disposition de traitements sûrs, efficaces et abordables aux patients les plus né... more
Accessed on 04.04.2023 La Iniciativa Medicamentos para Enfermedades Olvidadas (DNDi) es una organización internacional sin fines de lucro que proporciona tratamientos seguros, eficaces y asequibles para los pacientes más desatendidos, desde el laboratorio hasta su llegada a las manos de ... more
Accessed on 04.04.2023 The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit organization that discovers, develops, and delivers safe, effective, and affordable treatments for the most neglected patients
Website last accessed on 22.05.2023 The LEAP platform aims to strengthen clinical research capacity, which is lacking in part due to the remoteness and geographic spread of the patients, most of whom live in the most impoverished regions of Africa.
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife... more
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and... more
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the disease and both subspecies of the parasite, T.b. gambiense and T.b. rhodesiense. T.b. rhodesiense is ... more
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th... more
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified treatment which can be orally administered, impl... more
Diabetes Poster - Does your child show any of these symptoms?
Chagas is a parasitic disease that affects over 6 million people in the world. As the disease typically remains asymptomatic for years, new cases often go unnoticed and unreported, and most people with the disease are unaware of their condition. Less than 10% of people affected are diagnosed and... more
Website last accessed on 14.04.2023 Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f... more
La enfermedad de Chagas es parasitaria y afecta a más de 6 millones de personas en el mundo. Como normalmente es asintomática durante años, los nuevos casos suelen no detectarse ni reportarse y la mayoría de las personas con la enfermedad no tiene conciencia de su condición. Se diagnostica ... more
Full Perscribing information on Fexinidazole Tablet for oral use INDICATIONS AND USAGE Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati... more
Mycetoma is a slow-growing bacterial or fungal infection, most often of the foot, that may spread to other parts of the body and can cause severe deformity. It is a debilitating disease that most often affects poor people in rural areas with limited access to health care.
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P... more
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.